Eurizon Capital SGR S.p.A. Sells 11,192 Shares of Agilent Technologies, Inc. $A

Eurizon Capital SGR S.p.A. lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 195,626 shares of the medical research company’s stock after selling 11,192 shares during the quarter. Eurizon Capital SGR S.p.A.’s holdings in Agilent Technologies were worth $33,738,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Markowski Investments bought a new position in shares of Agilent Technologies in the 2nd quarter worth $27,000. Keating Financial Advisory Services Inc. bought a new stake in Agilent Technologies during the second quarter valued at about $31,000. Signature Equity Partners LLC boosted its position in Agilent Technologies by 172.7% during the third quarter. Signature Equity Partners LLC now owns 180 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in Agilent Technologies during the third quarter valued at about $32,000. Finally, Osterweis Capital Management Inc. purchased a new position in Agilent Technologies in the second quarter valued at about $43,000.

Analyst Ratings Changes

Several equities analysts have issued reports on A shares. UBS Group lifted their target price on Agilent Technologies from $165.00 to $180.00 in a research note on Tuesday, October 13th. Citigroup increased their price target on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Royal Bank Of Canada raised their price target on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Stifel Nicolaus lifted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $181.45.

Insider Buying and Selling at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director owned 4,924 shares in the company, valued at $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Agilent Technologies Stock Performance

Shares of A opened at $173.99 on Friday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The firm has a market cap of $49.05 billion, a PE ratio of 28.55, a P/E/G ratio of 2.53 and a beta of 1.24. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $182.99. The stock has a fifty day moving average price of $168.41 and a 200-day moving average price of $138.19.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the business earned $1.37 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were paid a dividend of $0.2550 per share. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

About Agilent Technologies

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.